(Q36330650)

13 August 2017

Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease (English)

1 reference

13 August 2017

bronchoalveolar lavage

1 reference

interstitial lung disease

inferred from title

1 reference

1

Charlie Strange

1 reference

13 August 2017

Marcy B Bolster

2

1 reference

13 August 2017

Michael D Roth

3

1 reference

13 August 2017

Richard M Silver

4

1 reference

13 August 2017

Arthur Theodore

5

1 reference

13 August 2017

Jonathan Goldin

6

1 reference

13 August 2017

Philip Clements

7

1 reference

13 August 2017

Joanie Chung

8

1 reference

13 August 2017

Robert M Elashoff

9

1 reference

13 August 2017

Robert Suh

10

1 reference

13 August 2017

Edwin A Smith

11

1 reference

13 August 2017

Daniel E Furst

12

1 reference

13 August 2017

Donald P Tashkin

13

1 reference

13 August 2017

Scleroderma Lung Study Research Group

14

1 reference

13 August 2017

language of work or name

English

0 references

publication date

27 September 2007

1 reference

American Journal of Respiratory and Critical Care Medicine

13 August 2017

1 reference

13 August 2017

177

1 reference

13 August 2017

1

1 reference

13 August 2017

91-98

1 reference

Cyclophosphamide versus placebo in scleroderma lung disease.

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Evaluation and management of alveolitis and interstitial lung disease in scleroderma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Computed tomography-guided bronchoalveolar lavage in idiopathic pulmonary fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Standardization of Spirometry, 1994 Update. American Thoracic Society

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Pulmonary manifestations of scleroderma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Prognostic role of eosinophils in pulmonary fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration?

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Severe restrictive lung disease in systemic sclerosis.

29 June 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200705-655OC

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200705-655OC

BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200705-655OC

Pulmonary function tests, high-resolution computerized tomography, alpha1-antitrypsin measurement, and early detection of pulmonary involvement in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200705-655OC

Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200705-655OC

Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200705-655OC

The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176114

Interstitial Pneumonia in Progressive Systemic Sclerosis: Serial High-Resolution CT Findings with Functional Correlation

22 September 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200705-655OC

Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage

21 January 2018

1 reference

12 December 2020

Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance

1 reference

12 December 2020

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1 reference

12 December 2020

Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee

1 reference

12 December 2020

[Latent alveolitis in systemic disease. The transition between the normal and the pathological]

1 reference

12 December 2020

Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage

1 reference

12 December 2020

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease

1 reference

12 December 2020

Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study

1 reference

12 December 2020

Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung

1 reference

12 December 2020

Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma

1 reference

12 December 2020

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

1 reference

12 December 2020

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

12 December 2020

Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis

1 reference

12 December 2020

A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease

1 reference

12 December 2020

Manifestations of scleroderma pulmonary disease

1 reference

12 December 2020

Bronchiectasis in systemic sclerosis. A study using high resolution computed tomography

1 reference

12 December 2020

Interstitial lung disease in systemic sclerosis

1 reference

12 December 2020

10.1164/RCCM.200705-655OC

Identifiers

DOI

1 reference

13 August 2017

1 reference

13 August 2017

1 reference